Ramakant Dixit, Sidharth Sharma, C L Nawal. Show Affiliations »
Abstract
Entities: Chemical
Mesh： See more » AdultAntitubercular Agents/administration & dosageAntitubercular Agents/adverse effectsDose-Response Relationship, DrugDrug Administration ScheduleDrug Therapy, CombinationGynecomastia/drug therapyHumansIndiaIsoniazid/adverse effectsIsoniazid/therapeutic useMalePyrazinamide/administration & dosagePyrazinamide/adverse effectsRifampin/administration & dosageRifampin/adverse effectsTuberculosis, Lymph Node/drug therapy
Substances： See more » Antitubercular AgentsPyrazinamideIsoniazidRifampin
Year: 2008 PMID： 18700651
Source DB: PubMed Journal: J Assoc Physicians India ISSN： 0004-5772